Labcorp Holdings Inc.
LH
$270.62
$3.771.41%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.52B | 3.56B | 3.53B | 3.35B | 3.33B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.52B | 3.56B | 3.53B | 3.35B | 3.33B |
| Cost of Revenue | 2.52B | 2.54B | 2.48B | 2.40B | 2.43B |
| Gross Profit | 993.20M | 1.03B | 1.05B | 948.00M | 896.30M |
| SG&A Expenses | 549.70M | 552.40M | 579.30M | 546.00M | 595.20M |
| Depreciation & Amortization | 72.60M | 69.50M | 68.30M | 69.60M | 70.40M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.14B | 3.16B | 3.13B | 3.01B | 3.10B |
| Operating Income | 370.90M | 403.20M | 398.60M | 332.40M | 230.70M |
| Income Before Tax | 190.60M | 337.00M | 304.70M | 275.20M | 183.80M |
| Income Tax Expenses | 25.70M | 75.50M | 66.40M | 62.20M | 40.20M |
| Earnings from Continuing Operations | 164.90M | 261.50M | 238.30M | 213.00M | 143.60M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -200.00K | -400.00K | -400.00K | -200.00K | -200.00K |
| Net Income | 164.70M | 261.10M | 237.90M | 212.80M | 143.40M |
| EBIT | 370.90M | 403.20M | 398.60M | 332.40M | 230.70M |
| EBITDA | 549.40M | 574.20M | 568.90M | 499.20M | 408.80M |
| EPS Basic | 2.00 | 3.14 | 2.85 | 2.55 | 1.72 |
| Normalized Basic EPS | 2.39 | 2.56 | 2.54 | 2.10 | 1.50 |
| EPS Diluted | 1.97 | 3.12 | 2.84 | 2.52 | 1.71 |
| Normalized Diluted EPS | 2.37 | 2.54 | 2.53 | 2.09 | 1.49 |
| Average Basic Shares Outstanding | 82.50M | 83.10M | 83.40M | 83.60M | 83.60M |
| Average Diluted Shares Outstanding | 83.20M | 83.70M | 83.90M | 84.30M | 84.20M |
| Dividend Per Share | 0.72 | 0.72 | 0.72 | 0.72 | 0.72 |
| Payout Ratio | 36.00% | 22.94% | 25.18% | 28.95% | 41.91% |